Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Respiratory System

Respiratory diseases affect the organs responsible for gas exchange and include obstructive conditions such as asthma and chronic bronchitis, infectious diseases, and inflammatory or fibrotic lung disorders. Emerging respiratory pathogens, including novel viral infections, further underscore the need for robust pulmonary research. Investigations into airway inflammation, immune responses, and tissue remodeling are critical for improving respiratory health outcomes.

Y-27632 dihydrochloride
Y-27632 2HCl
T1725129830-38-2
Y-27632 dihydrochloride (Y-27632 2HCl) is an orally potent, ATP-competitive inhibitor of ROCK-I and ROCK-II. Y-27632 dihydrochloride also inhibits isolation-induced apoptosis in mouse prostate stem or progenitor cells.
  • $31
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Lipopolysaccharides
LPS
T11855
Lipopolysaccharides (LPS), derived from Escherichia coli O55:B5, are essential components of the outer membrane of Gram-negative bacteria. Composed of lipid A, a core oligosaccharide, and an O-specific polysaccharide, LPS exhibits strong immunogenicity. It activates immune cells via the TLR4 receptor, induces chemotactic cell migration and cytokine secretion, and helps maintain the integrity of the bacterial outer membrane, protecting against bile salts and lipid-based antibiotics. LPS is commonly used to establish inflammatory models, including arthritis, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and gastrointestinal disease models.
  • $45
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Y-27632
T1870146986-50-7
Y-27632 is an orally potent, ATP-competitive inhibitor of ROCK-I and ROCK-II. Y-27632 also inhibits isolation-induced apoptosis in mouse prostate stem or progenitor cells.
  • $31
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Tezepelumab
Tezepelumab-ekko, MEDI 19929, AMG 157
T773591572943-04-4
Tezepelumab (AMG 157) is a humanized monoclonal antibody (IgG2λ) targeting TSLP that prevents TSLP from interacting with its heterodimer receptor. Tezepelumab can be used to study advanced asthma disease.
  • $1,060
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Pirfenidone
S-7701,AMR-69, S-7701, AMR69
T238653179-13-8
Pirfenidone (AMR69) inhibits the production of CCL2 and CCL12 in fibroblasts and also decreases TGF-β2 protein levels. Pirfenidone is an antifibrotic agent that is commonly used in studies related to pulmonary fibrosis and also has anti-inflammatory activity.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Tanzisertib
CC-930
T14895899805-25-5
Tanzisertib (CC-930) (CC-930) is a potent inhibitor of JNK1/2/3 with IC50s of 61/7/6 nM, respectively, with potential antifibrotic activity.
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Lurbinectedin
PM01183
T15793497871-47-3
Lurbinectedin (PM01183) is a DNA minor groove covalent binder that demonstrates effective anti-tumor activity.
  • $198
In Stock
Size
QTY
TD139
T51211450824-22-2In house
TD139 is a small molecule inhibitor of inhaled galectin-3 (Gal-3) with potential anti-fibrotic activity, commonly used in the study of idiopathic pulmonary fibrosis.
  • $64
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
GW3965 hydrochloride
GW3965 HCl
T6310405911-17-3
GW3965 hydrochloride (GW3965 HCl) is an effective and specific LXR agonist for hLXRα/β (EC50: 190/30 nM).
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
SQ109
NSC 722041
T16925502487-67-4
SQ109 (NSC-722041) is an effective inhibitor of the trypomastigote form of the parasite (IC50 = 50 nM). SQ109 is an antitubercular agent and targets MmpL3.
  • $50
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Quercetin
Sophoretin
T2174117-39-5
Quercetin, a flavonoid natural product, is a SIRT1 activator. It is also a PI3K inhibitor, inhibiting PI3Kγ, PI3Kδ, and PI3Kβ with IC50 values of 2.4, 3.0, and 5.4 μM, respectively. Recognized as a heat shock protein inhibitor, Quercetin can significantly reduce exosome release in TII models by downregulating Hsp70 or Hsp90.
  • $42
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Nirmatrelvir
T93512628280-40-8
PF-07321332 is a potent and orally active inhibitor of SARS-CoV 3C-like protease (3CLPRO) .
  • $53
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Nerandomilast
BI 1015550
T720311423719-30-5
Nerandomilast (BI 1015550) is an orally active PDE4B inhibitor with IC50 of 7.2 nM. BI 1015550 has potential applications in inflammation, allergic diseases, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD) with a good safety profile.
  • $59
In Stock
Size
QTY
Mitiperstat
AZD4831
T610281933460-19-5
Mitiperstat is a potent myeloperoxidase (MPO) inhibitor that is effective in preventing cardiovascular diseases such as heart failure and coronary artery disease.
  • $158
In Stock
Size
QTY
Razuprotafib
AKB-9778
T167241008510-37-9
Razuprotafib (AKB-9778) is a protein tyrosine phosphatase ß (HPTPß) inhibitor with an IC50 of 50 nM. It effectively activates Tie-2 and provides protection against acute kidney injury.
  • $253
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Rosiglitazone
BRL49653
T0334122320-73-4
Rosiglitazone (BRL49653) is a PPARγ agonist, TRPC5 activator, and TRPM3 inhibitor with oral activity. Rosiglitazone is also a hypoglycemic agent and a thiazolidinedione insulin sensitizer.
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Curcumin
Turmeric yellow, Natural Yellow 3, Indian Saffron, Diferuloylmethane
T1516458-37-7
Curcumin (Natural Yellow 3) is a phenolic natural product, an inhibitor of histone acetyltransferase p300/CREB (IC50=25 μM) with specificity. Curcumin has a wide range of pharmacological activities such as antitumor, anti-inflammatory and antioxidant.
  • $37
In Stock
Size
QTY
TargetMol | Citations Cited
Ensifentrine
Ensifentrinum, Ensifentrina
T253761884461-72-6
Ensifentrine (Ensifentrinum) is a PDE3/4 inhibitor, although its affinity for PDE3(IC50: 0.4 nM) is 3,440 times higher than that for PDE4(IC50: 1479 nM), that is under clinical development for the treatment of asthma and COPD and, potentially, cystic fibrosis.
  • $30
In Stock
Size
QTY
Palmitic acid
Hexadecoic acid, hexadecanoic acid, Cetylic acid
T290857-10-3
Palmitic acid (Cetylic acid) is a natural product, a common saturated fatty acid found in animals, plants and microorganisms. Palmitic acid has antitumor activity.
  • $48
In Stock
Size
QTY
TargetMol | Citations Cited
Astaxanthin
β-Carotene-4,4'-dione, trans-Astaxanthin, Ovoester, AstaREAL
T3138472-61-7
Astaxanthin (trans-Astaxanthin) is a keto-carotenoid in the terpenes class of chemical compounds. It is classified as a xanthophyll but it is a carotenoid with no vitamin A activity. It is present in most red-colored aquatic organisms. Astaxanthin has shown to mediate anti-oxidant and anti-inflammatory actions. It may be found in fish feed or some animal food as a color additive.
  • $30
In Stock
Size
QTY
Enzaplatovir
BTA-C585, BTAC585, BTA-585, BTA585, BTA 585
T272711323077-89-9In house
Enzaplatovir (BTA-585) is an orally available fusion inhibitor with antiviral activity for the study of respiratory syncytial virus infections and coronavirus disease (COVID-19) infections.
  • $107
In Stock
Size
QTY
Methyl-β-cyclodextrin
Methyl-beta-cyclodextrin, beta-Cyclodextrin methyl ethers
T4072128446-36-6
Methyl-β-cyclodextrin (Methyl-beta-cyclodextrin) is a macrocyclic compound utilized as a solubilizer for hydrophobic substances in biological studies, and serves as a lipid raft inhibitor with cholesterol-lowering and potential antitumor activities.
  • $33
In Stock
Size
QTY
TargetMol | Citations Cited
AS1517499
T4476919486-40-1
AS1517499 is a blood-brain barrier permeable inhibitor of STAT6 phosphorylation (IC50= 21 nM).
  • $34
In Stock
Size
QTY
TargetMol | Citations Cited
SP600125
Pyrazolanthrone, Nsc75890, JNK Inhibitor II, 1PMV
T3109129-56-6
SP600125 (JNK Inhibitor II) is a JNK inhibitor that inhibits JNK1, JNK2, and JNK3 (IC50=40/40/90 nM) with oral potency, reversibility, and ATP-competitive properties. SP600125 inhibits autophagy and induces apoptosis.
  • $41
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited